ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,269, issued on Nov. 18, was assigned to ASKBIO INC..
"Liver-specific inducible promoters and methods of use thereof" was invented by Michael Roberts (Midlothian, Great Britain), Graham Whyteside (Midlothian, Great Britain) and Anne Braae (Midlothian, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to inducible regulatory elements, promoters and vectors, especially gene therapy vectors, and methods of their use."
The patent was filed on Jan. 20, 2020, under Application No. 17/423,693.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect...